187 related articles for article (PubMed ID: 36008229)
21. Type of CFTR mutation determines risk of pancreatitis in patients with cystic fibrosis.
Ooi CY; Dorfman R; Cipolli M; Gonska T; Castellani C; Keenan K; Freedman SD; Zielenski J; Berthiaume Y; Corey M; Schibli S; Tullis E; Durie PR
Gastroenterology; 2011 Jan; 140(1):153-61. PubMed ID: 20923678
[TBL] [Abstract][Full Text] [Related]
22. Changing paradigms in the treatment of gastrointestinal complications of cystic fibrosis in the era of cystic fibrosis transmembrane conductance regulator modulators.
Konrad J; Eber E; Stadlbauer V
Paediatr Respir Rev; 2022 Jun; 42():9-16. PubMed ID: 33485777
[TBL] [Abstract][Full Text] [Related]
23. Pancreatitis severity in mice with impaired CFTR function but pancreatic sufficiency is mediated via ductal and inflammatory cells-Not acinar cells.
Trapp S; Aghdassi AA; Glaubitz J; Sendler M; Weiss FU; Kühn JP; Kromrey ML; Mahajan UM; Pallagi P; Rakonczay Z; Venglovecz V; Lerch MM; Hegyi P; Mayerle J
J Cell Mol Med; 2021 May; 25(10):4658-4670. PubMed ID: 33682322
[TBL] [Abstract][Full Text] [Related]
24. Lack of CFTR alters the ferret pancreatic ductal epithelial secretome and cellular proteome: Implications for exocrine/endocrine signaling.
Rotti PG; Evans IA; Zhang Y; Liang B; Cunicelli N; O'Malley Y; Norris AW; Uc A; Engelhardt JF
J Cyst Fibros; 2022 Jan; 21(1):172-180. PubMed ID: 34016558
[TBL] [Abstract][Full Text] [Related]
25. A foetus with cystic fibrosis - To treat or not to treat?
Padmakumar N; Khan HS
Respir Med Res; 2023 Jun; 83():101006. PubMed ID: 37037055
[TBL] [Abstract][Full Text] [Related]
26. Pancreatitis and pancreatic cystosis in Cystic Fibrosis.
Freeman AJ; Ooi CY
J Cyst Fibros; 2017 Nov; 16 Suppl 2():S79-S86. PubMed ID: 28986028
[TBL] [Abstract][Full Text] [Related]
27. Analysis of cystic fibrosis gener product (CFTR) function in patients with pancreas divisum and recurrent acute pancreatitis.
Gelrud A; Sheth S; Banerjee S; Weed D; Shea J; Chuttani R; Howell DA; Telford JJ; Carr-Locke DL; Regan MM; Ellis L; Durie PR; Freedman SD
Am J Gastroenterol; 2004 Aug; 99(8):1557-62. PubMed ID: 15307877
[TBL] [Abstract][Full Text] [Related]
28. Time for a gut check: Pancreatic sufficiency resulting from CFTR modulator use.
Megalaa R; Gopalareddy V; Champion E; Goralski JL
Pediatr Pulmonol; 2019 Aug; 54(8):E16-E18. PubMed ID: 31066218
[TBL] [Abstract][Full Text] [Related]
29. Cystic Fibrosis Transmembrane Conductance Regulator Modulator Therapy: A Review for the Otolaryngologist.
Lee SE; Farzal Z; Daniels MLA; Thorp BD; Zanation AM; Senior BA; Ebert CS; Kimple AJ
Am J Rhinol Allergy; 2020 Jul; 34(4):573-580. PubMed ID: 32168995
[TBL] [Abstract][Full Text] [Related]
30. Evaluation of fecal pancreatic elastase-1 as a measure of pancreatic exocrine function in children with cystic fibrosis.
Cade A; Walters MP; McGinley N; Firth J; Brownlee KG; Conway SP; Littlewood JM
Pediatr Pulmonol; 2000 Mar; 29(3):172-6. PubMed ID: 10686036
[TBL] [Abstract][Full Text] [Related]
31. Faecal elastase-1 concentration in cystic fibrosis patients with CFTR I1234V mutation.
Abdel Rahman H; Abdul Wahab A; Abdel Rahman MO; Mostafa OA
Acta Paediatr; 2006 Sep; 95(9):1066-9. PubMed ID: 16938751
[TBL] [Abstract][Full Text] [Related]
32. Cystic fibrosis and related diseases of the pancreas.
Naruse S; Kitagawa M; Ishiguro H; Fujiki K; Hayakawa T
Best Pract Res Clin Gastroenterol; 2002 Jun; 16(3):511-26. PubMed ID: 12079272
[TBL] [Abstract][Full Text] [Related]
33. Serum zinc concentration in cystic fibrosis patients with CFTR I1234V mutation associated with pancreatic sufficiency.
AbdulWahab A; Abushahin A; Allangawi M; Chandra P; Abdel Rahman MO; Soliman A
Clin Respir J; 2017 May; 11(3):305-310. PubMed ID: 26096753
[TBL] [Abstract][Full Text] [Related]
34. Early decline of pancreatic function in cystic fibrosis patients with class 1 or 2 CFTR mutations.
Walkowiak J; Sands D; Nowakowska A; Piotrowski R; Zybert K; Herzig KH; Milanowski A
J Pediatr Gastroenterol Nutr; 2005 Feb; 40(2):199-201. PubMed ID: 15699697
[TBL] [Abstract][Full Text] [Related]
35. The Extrapulmonary Effects of Cystic Fibrosis Transmembrane Conductance Regulator Modulators in Cystic Fibrosis.
Sergeev V; Chou FY; Lam GY; Hamilton CM; Wilcox PG; Quon BS
Ann Am Thorac Soc; 2020 Feb; 17(2):147-154. PubMed ID: 31661636
[TBL] [Abstract][Full Text] [Related]
36. [Pancreatic infringement exocrine and endocrine in cystic fibrosis].
Kessler L; Abély M
Arch Pediatr; 2016 Dec; 23(12S):12S21-12S32. PubMed ID: 28231890
[TBL] [Abstract][Full Text] [Related]
37. Targeting a genetic defect: cystic fibrosis transmembrane conductance regulator modulators in cystic fibrosis.
Derichs N
Eur Respir Rev; 2013 Mar; 22(127):58-65. PubMed ID: 23457166
[TBL] [Abstract][Full Text] [Related]
38. Emerging medicines to improve the basic defect in cystic fibrosis.
Fajac I; Sermet-Gaudelus I
Expert Opin Emerg Drugs; 2022 Sep; 27(3):229-239. PubMed ID: 35731915
[TBL] [Abstract][Full Text] [Related]
39. Cystic Fibrosis of the Pancreas: The Role of CFTR Channel in the Regulation of Intracellular Ca
Madácsy T; Pallagi P; Maleth J
Front Physiol; 2018; 9():1585. PubMed ID: 30618777
[TBL] [Abstract][Full Text] [Related]
40. Loss of cftr function leads to pancreatic destruction in larval zebrafish.
Navis A; Bagnat M
Dev Biol; 2015 Mar; 399(2):237-48. PubMed ID: 25592226
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
